Legal Representation
Attorney
EDWARD W. GOODMAN, EDWARD BLOCKER, MICHAEL E. MARION, DAVID SCHREIBER
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description |
|---|---|---|---|
| Oct 7, 2019 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Oct 7, 2019 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Mar 5, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jan 8, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jan 8, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 19, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Nov 20, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Nov 1, 2018 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Nov 1, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Nov 1, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Aug 10, 2018 | CNSL | R | SUSPENSION LETTER WRITTEN |
| Aug 10, 2018 | GNSL | S | LETTER OF SUSPENSION E-MAILED |
| Aug 10, 2018 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Aug 8, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 8, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Aug 8, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 13, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Feb 13, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Feb 13, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Feb 7, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
| Feb 1, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jan 25, 2018 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 009
Software for application in the medical field and in healthcare, namely, software for receiving patient information including genomic sequencing data and clinical data, and for providing the results of genomic processing for generating reports and for delivering biomarker-informed therapy choices and clinical trial matching
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Software as a service (SaaS) featuring software for receiving patient information including genomic sequencing data and clinical data, and for providing the results of genomic processing for generating reports and for delivering biomarker-informed therapy choices and clinical trial matching
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
009
042